|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||
| Depreciation and amortization | |||
| Amortization of deferred financing costs | |||
| Loss from the disposal of fixed assets | |||
| Stock-based compensation | |||
| Amortization, net, of premium/discount on marketable securities | |||
| Deferred taxes | |||
| Excess net tax provision related to share-based awards | |||
| Loss on disposal of fixed assets | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable from collaborations | |||
| Prepaid expenses and other current assets | |||
| Accounts payable | |||
| Accrued liabilities | |||
| Accrued compensation | |||
| Deferred rent and lease incentives | |||
| Deferred revenue from collaborations | |||
| Other assets | |||
| Net cash (used in) provided by operating activities | |||
| Cash flows from investing activities | |||
| Purchases of marketable securities available for sale | |||
| Maturities of marketable securities available for sale | |||
| Net additions to property and equipment | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities | |||
| Repurchase of restricted stock units related to tax withholdings | |||
| Value of equity awards withheld for tax liability | |||
| Proceeds from issuance of common stock | |||
| Restricted investments income | |||
| Sale of stock, net | |||
| Payments for deferred offering costs | |||
| Excess tax benefit from stock-based compensation | |||
| Net cash provided by (used in) financing activities | |||
| Increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents—beginning of period | |||
| Cash and cash equivalents—end of period | |||
| Supplemental disclosure | |||
| Cash paid for interest | |||
| Cash paid for income taxes | |||
| Unpaid deferred offering costs | |||
| Restriction of investment as collateral | |||
| Conversion of convertible preferred stock upon IPO | |||
| Conversion of contingently convertible debt, related party, upon IPO |
Loading...
